Back to search

Article

TCR/CD3-based synthetic antigen receptors (TCC) convey superior antigen sensitivity combined with high fidelity of activation

2023-03-17

Abstract excerpt

<h4>ABSTRACT</h4> Low antigen sensitivity and a gradual loss of effector functions limit the clinical applicability of chimeric antigen receptor (CAR)-modified T-cells and call for alternative antigen receptor designs for effective T-cell-based cancer immunotherapy. Here we applied advanced microscopy to demonstrate that TCR/CD3-based synthetic constructs (TCC) outperform second-generation CAR formats with regard...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9dfd846d-c3d4-5014-b68e-e988da87d5c7
DOI
10.1101/2023.03.16.532775
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
TCR/CD3-based synthetic antigen receptors (TCC) convey superior antigen sensitivity combined with high fidelity of activationDOI 10.1101/2023.03.16.532775
Select a neighboring publication to make it the new centre.